Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | — |
underage; wrong dose in schedule; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 9-month-old male patient who received DTPa-IPV (Kinrix) for prophylaxis. On 20-FEB-2025, the patient received the 3rd dose of Kinrix. On 20-FEB-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: underage) and wrong vaccine administered (Verbatim: wrong dose in schedule). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-FEB-2025 The physician reported that a 9 month old patient received Kinrix in error, which led to inappropriate age at vaccine administration. Patient was due for DTaP and IPV, which led to wrong vaccine administered. Kinrix was the patient's 3rd dose of each. The patient received their 2nd dose of a DTaP and an IPV on 19-NOV-2024(no mention of brand).